Wednesday, February 23, 2022 12:38:27 PM
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Recent HIMS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:16:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 09:05:00 PM
- Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide • Business Wire • 05/21/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 11:39:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 12:17:31 PM
- Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment • Business Wire • 05/19/2026 03:59:00 AM
- Hims & Hers Shares Slide After Convertible Notes Offering Announcement (HIMS) • IH Market News • 05/18/2026 02:01:53 PM
- Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment • Business Wire • 05/18/2026 11:16:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 04:30:47 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (Canada) • 05/12/2026 02:30:00 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (US) • 05/12/2026 02:30:00 PM
- Hims & Hers (HIMS) Shares Slide After Surprise First-Quarter Loss • IH Market News • 05/12/2026 01:01:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 08:15:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 08:08:27 PM
- Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results • Business Wire • 05/11/2026 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 12:41:07 PM
- Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors • Business Wire • 04/28/2026 12:35:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 12:25:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 12:23:47 PM
- Hims & Hers jumps 7% after expanding partnership with Eli Lilly • IH Market News • 04/23/2026 02:06:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:24:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:24:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/20/2026 08:38:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/20/2026 05:19:21 PM
- Hims & Hers Shares Jump on Proposed FDA Peptide Rule Changes • IH Market News • 04/16/2026 11:27:25 AM
